2003-2005: organization and structuring
2003 Creation of the Novacap group, Bain Capital is the majority shareholder of the group
2004 Start-up of a new sodium bicarbonate unit
2006-2011: organic development improvement
2006 Start-up of the calcium chloride unit in Pont-de-Claix (Performance Chemicals)
2008 Start-up of the second sodium bicarbonate unit (Mineral Specialties)
2010 Start-up of the Isopropanol unit in Roussillon (Performance Chemicals)
2011 Ardian acquires 96% of Novacap
2011-2017: growth acceleration with an international footprint
2011 Start-up of the third sodium bicarbonate unit (Mineral Specialties)
2011 Acquisition of Novacyl (Pharmaceutical & Cosmetics division)
2011 Start-up of a new ferric chloride production unit in Pont-de-Claix (France)
2012 Capacity expansion on Alpha Methyl Styrene (Performance Chemicals)
2013 Acquisition of a controlling stake (51%) in Yangzi Pharmaceutical Chemical in China (Pharmaceutical & Cosmetics)
2014 Launch of homosalate(Pharmaceutical & Cosmetics), sodium silicates (Mineral Specialties)
Acquisition of a 51% controlling stake in Puyan (Pharmaceutical & Cosmetics)
2015 Acquisition of Uetikon (Pharmaceutical & Cosmetics) a German based APIs and Fine Chemicals manufacturer
2016 EURAZEO becomes the majority shareholder of the group alongside MERIEUX DEVELOPPEMNT, ARDIAN and the management team.
Since 2016 : Strengthening of technological and products offering for pharmaceutical, cosmetics and fine chemistry markets.
2017 Novacap acquires 96,5% of Puyuan (Pharmaceutical & Cosmetics)
2017 Novacap acquires 77,57% of Yangzi Pharmaceutical Chemical (Pharmaceutical & Cosmetics)
April 2017 Novacap announced a project of strategic combination with PCAS, specialising in the development and production of complex molecules for life sciences and innovative technologies, through a sale of blocks of shares followed by a tender offer.
April 2017 Startup of a new production unit of manufacture of DIPE (Diisopropyl Ether) on the Roussillon chemical platform.
May 2017 Novacap acquires ID bio, a manufacturer of botanical ingredients and H2B, a manufacturer of ingredients for in vitro diagnosis.
May 2017 Novacap acquires PCAS, specializes in the development and production of complex molecules for life sciences and innovative technologies.